Scleroderma with systemic involvement (progressive systemic sclerosis) is an unusual but not rare disease. Its clinical and laboratory features have been analysed in some detail in numerous papers, reviewed in a recent monograph.' Ocular involvement in scleroderma is widely recognised,2-but the nature, frequency, and relevance of the ocular changes remain the subject of some uncertainty. The occurrence of severe fundal changes in acute terminal renal failure associated with scleroderma has been well documented.5 The purpose of this paper is to explore the clinically significant ocular features in a group of patients affected by scleroderma of different degrees of severity but not in renal failure. Patients all had evidence of some systemic disorder either clinically or on tests.
The patients were subjected to a careful ophthalmic assessment, including applanation tonometry, biomicroscopy of the anterior segment and vitreous, and examination of the ocular fundus by direct and indirect ophthalmoscopy after the instillation of mydriatic drops.
We sought sludging or segmentation of the blood columns in conjunctival vessels mainly of venular calibre, using biomicroscopic magnification. The appearance of the vitreous fibrils was assessed minutely by biomicroscopy and contact lens examination, with particular reference to thickening, nodularity, or cellular deposits in the vitreous framework. Stiffness and loss of elasticity of eyelid skin was assessed subjectively. Lacrimal function was assessed by examination of the cornea and conjunctiva after the instillation of Rose-Bengal drops and by a Schirmer test,7 wetting of the filter paper strip less than 10 mm after 5 minutes being taken as indicating reduced tear secretion.
Results
Eyelid changes. Tightness of the skin of the eyelids was found mainly in type 2 cases. Associated shortening of the interpalpebral fissure as reported by Kirkham3 was found in only 1 patient. Telangiectases of the eyelid skin were generally tiny, seldom exceeding 1 mm in diameter, and were best detected under biomicroscopic magnification.
Lacrimal function. 
Discussion
The retinal changes in scleroderma with advanced renal failure have been described5 but are not applicable to the patients in this study. Other writers have described the following changes in scleroderma without renal failure: eyelid sclerosis and telangiectasis,2 4 conjunctival congestion or oedema,2 defects of lacrimal secretion,2 3 iris atrophy, and retinal exudates.4 However, no systematic study of ocular changes in a large number of patients as presented has been reported previously.
In considering the large variety of ocular abnormalities revealed in this study some separation of the changes may be made provisionally into those related to the age of the individual, those due to previous or current treatment, and those due to scleroderma or associated disease.
Presumed age-related abnormalities. Certain of the abnormalities-cuneiform and nuclear lens opacities, vitreous frosting (the 'senile peppering' of Koby8), colloid bodies of the posterior pole, and retinal arteriosclerosis, are age-related, and their incidence would not appear to differ markedly from that in the general population. Raised intraocular pressure, found in 2 of the 38 patients, is consistent with a spontaneous partial manifestation of chronic simple glaucoma in a middle-aged and elderly population. One of these patients had been on systemic steroid therapy, but steroid provocative testing failed to support the possibility of a steroidinduced glaucoma.
Changes presumably related to treatment. Posterior subcapsular lens opacities were noted in 1 patient who had been treated with systemic corticosteroids for many years. Her lenses were later extracted with a good visual result.
Changes probably related to scleroderma. The following changes, not explicable by age or treatment, were probably related to scleroderma: eyelid changes, conjunctival changes, lacrimal disturbance. 
Conclusion
Ocular changes which appear to be specifically related to scleroderma include: telangiectasia and dermal sclerosis of the eyelids; a tear defect of varying severity; injection, telangiectasia, and sludging of the blood column in conjunctival vessels; possibly punctate defects of the iris pigment epithelium. Posterior subcapsular lens opacities in 1 case were attributed to long-term systemic steroid therapy.
